Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07209722 · ClinicalTrials.gov registry record
PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 1,377
- Enrollment target
NCT07209722 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1,377 participants.
The verdict
NCT07209722 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 1,377 participants
- Enrollment target
Study Summary
The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.
Interventions
- BEHAVIORAL PrEP acronym (pre-exposure prophylaxis)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,377 participants |
| Start Date | 2023-09-22 |
| Est. Completion | 2025-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07209722
The ClinicalTrials.gov registry entry for NCT07209722 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,377 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PrEP acronym (pre-exposure prophylaxis) is the first listed.
NCT07209722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07209722 about?
NCT07209722 is a clinical study titled "PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare". The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescr...
What is the current status of trial NCT07209722?
This trial is currently completed. The enrollment target is 1,377 participants. The study started on 2023-09-22. Estimated completion is 2025-08-16.
What interventions are being tested in trial NCT07209722?
The interventions under investigation include: PrEP acronym (pre-exposure prophylaxis) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07209722?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.